Sunday, 13 November 2016

PRO/EDR> Meningitis, meningococcal - Italy (06): (TC) duration of vaccine effectiveness

Meningitis - Neisseria -- Italy
1..
2. .
--
Communicated by:
Pasquale Urbano
Dept. of Public Health,
University of Florence (retired)
Florence, Italy

[ProMED-mail thanks Prof. Urbano for his continued contributions.
This is another case in which an individual developed invasive meningococcal disease (IMD) due to serogroup C after having been recently vaccinated against _N. meningitis_ type C with a meningococcal serogroup C conjugate (MCC) vaccine in the campaign in the Tuscany Region to curb the IMD outbreak.

Read more about it at HealthMap Global Disease Alerts via http://bit.ly/2eRzqof

No comments:

Post a Comment